E3 ubiquitin-protein ligase (mouse double minute 2; Mdm2) protein expression is strongly associated with poor overall survival in malignant pleural mesothelioma

F. Mairinger, S. Ting, C. Vollbrecht, R. Walter, J. Kollmeier, S. Grief, T. Hager, T. Mairinger, D. Christoph, K. W. Schmid, J. Wohlschlaeger (Essen, Cologne, Berlin, Germany; Denver, United States Of America)

Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Session: Translational research to bridge the need within clinical decision making
Session type: Thematic Poster Session
Number: 543
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Mairinger, S. Ting, C. Vollbrecht, R. Walter, J. Kollmeier, S. Grief, T. Hager, T. Mairinger, D. Christoph, K. W. Schmid, J. Wohlschlaeger (Essen, Cologne, Berlin, Germany; Denver, United States Of America). E3 ubiquitin-protein ligase (mouse double minute 2; Mdm2) protein expression is strongly associated with poor overall survival in malignant pleural mesothelioma. Eur Respir J 2013; 42: Suppl. 57, 543

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A549 cell expression of ubiquitin E3 ligase RNF168 is decreased following RSV infection but increased by interferon beta treatment
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013


The diagnosis and incidence of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutation in lung adenocarcinoma
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015

Correlation between expression of p53, pRb, mdm2, p21WAF1/CIP1, PCNA, cyclin D1 and apoptotic index (AI) in non-small cell lung cancer (NSCLC) cells
Source: Annual Congress 2006 - Molecular pathology and genetics of lung cancer
Year: 2006


The proteasome subunits PSMA5 and PSMB4 are potent markers to discriminate between typical and atypical carcinoid tumors of the lung
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


The role of NPM, p14arf and MDM2 in precursors of bronchial squamous cell carcinoma
Source: Eur Respir J 2008; 32: 678-686
Year: 2008



BAP1 expression and treatment outcomes in malignant mesothelioma.
Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside
Year: 2017



Loss of orphan G protein coupled receptor GPRC5A is associated with metastatic disease and poor survival in patients with adenocarcinomas of the lung
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011

Akt induced cytoplasmic mislocalization of p27kip1 protein and correlated with poor prognosis in lung adenocarcinoma
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Expression of survivin and p53 protein in pulmonary tumours
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011

Translocation of beta-catenin into cytoplasm during TGFbeta-induced EMT is negatively regulated by phosphorylation of the PTEN C-terminus in lung cancers
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013


Radiation/cisplatin/vinorelbine therapy increase p53 protein phosphorylated at serine 392 in recurrent primary squamous cell lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 17s
Year: 2001

Therapy increases poly(ADP-ribose), p53 expression, p53-Ser392 –P, and p53-Ser2 –P levels in recurrent squamous cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 14s
Year: 2002

An analysis of mRNA and long non-coding RNA (lncRNA) expression during the progression from pre-invasive lesions (PL) to invasive squamous cell carcinoma (SqCC) of the bronchus
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013


Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53
Source: Eur Respir J 2003; 21: 753-758
Year: 2003



Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer
Source: Eur Respir J 2004; 23: 14-19
Year: 2004



Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma
Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma
Year: 2006


Oral presentation: Truncated isoforms of BRCA1-associated protein BARD1 are expressed in NSCLC and are potential targets for treatment
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009



Expression of the ILK-PINCH-PARVIN (IPP) complex and its binding partner Rsu-1 in human non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016

Combined expression of p53, Bcl-2 and p21WAF-1 proteins in endobronchial biopsies may be associated with lung cancer prognosis
Source: Eur Respir J 2001; 18: Suppl. 33, 230s
Year: 2001

Oncogenic drivers (OD) and matched targeted agents (TA): Impact on overall survival in patients with lung adenocarcinoma (LA)?
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015